US Patent 11433100 Compositions and methods for treating ceacam positive cancers
Patent 11433100 was granted and assigned to A2 Biotherapeutics, Inc on September, 2022 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11433100 Compositions and methods for treating ceacam positive cancers
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
